[Observation on nasopharyngeal cancer treated by radiotherapy and oral levamisole].
Du
R S
RS
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000276:immunology; D002213:Capsid / Q000276:immunology; D036022:Capsid Proteins; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007978:Levamisole / Q000008:administration & dosage*; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D011446:Prospective Studies
D000956:Antigens, Viral; D036022:Capsid Proteins; C041788:Epstein-Barr viral capsid antigen; D007070:Immunoglobulin A; D007978:Levamisole